LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Open

4.36 17.52

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.5

Max

4.38

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M -13M
Verkäufe	-1.4M 17M
Gewinnspanne	-77.289
Angestellte	260
EBITDA	-3.2M -11M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+17.19% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	2.4M 123M
Vorheriger Eröffnungskurs	-13.16
Vorheriger Schlusskurs	4.36

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Feb. 2026, 23:57 UTC

Heiße Aktien

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12. Feb. 2026, 23:35 UTC

Ergebnisse

Wichtige Markttreiber

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12. Feb. 2026, 23:28 UTC

Ergebnisse

Applied Materials Profit Rises on Soaring AI Demand -- Update

12. Feb. 2026, 21:47 UTC

Ergebnisse

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13. Feb. 2026, 00:00 UTC

Market Talk

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12. Feb. 2026, 23:47 UTC

Market Talk

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12. Feb. 2026, 23:38 UTC

Market Talk

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12. Feb. 2026, 23:33 UTC

Ergebnisse

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12. Feb. 2026, 23:09 UTC

Market Talk

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12. Feb. 2026, 22:55 UTC

Ergebnisse

Heiße Aktien

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12. Feb. 2026, 22:46 UTC

Market Talk

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12. Feb. 2026, 22:23 UTC

Ergebnisse

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12. Feb. 2026, 22:15 UTC

Ergebnisse

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12. Feb. 2026, 22:00 UTC

Ergebnisse

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12. Feb. 2026, 22:00 UTC

Ergebnisse

12. Feb. 2026, 22:00 UTC

Ergebnisse

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12. Feb. 2026, 21:57 UTC

Ergebnisse

XP 4Q Rev BRL4.95B >XP

12. Feb. 2026, 21:52 UTC

Ergebnisse

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

12. Feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. Feb. 2026, 21:47 UTC

Ergebnisse

Morningstar 4Q Rev $641M >MORN

12. Feb. 2026, 21:39 UTC

Ergebnisse

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12. Feb. 2026, 21:38 UTC

Ergebnisse

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

17.19% Vorteil

12-Monats-Prognose

Durchschnitt 4.5 USD 17.19%

Hoch 5.5 USD

Tief 3.5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.